ACIU
AC Immune Ltd
2.50$
-5.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.2% | 112.8% | -24.3% | -109.1% | -612.7% | 50.0% | -385.7% | -6,958.6% | -1,869.6% | -408.1% | 241.1% | -1,851.3% | |
| 1.0% | 0.7% | 1.2% | 2.9% | 13.4% | 1.5% | 12.7% | 254.9% | 59.9% | 15.0% | 7.9% | 66.9% | |
| 0.7% | 1.4% | 5.7% | 7.8% | 35.0% | 2.6% | 26.5% | 437.1% | 84.6% | 29.5% | 20.0% | 123.0% | |
| 1.2% | -3.6% | -8.1% | 30.0% | 57.0% | 2.2% | 32.5% | -205.5% | 82.8% | – | – | – | |
| -95.4% | 62.9% | 14.2% | -9.8% | 25.2% | 5.1% | -29.6% | 724.7% | -214.3% | -102.4% | 393.7% | -181.1% | |
| 0.4% | 0.6% | 3.9% | 8.9% | 25.8% | 1.7% | 11.1% | 279.1% | 31.5% | 5.4% | 2.1% | 24.1% | |
| -0.4% | -0.6% | -3.9% | -9.1% | -445.3% | -60.6% | 183.6% | -5,684.7% | 603.9% | 443.5% | -385.6% | 1,698.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.2% | – | – | – | |
| 33.2% | 75.7% | 357.1% | 0.4% | 1,550.4% | 0.1% | -0.6% | 0.0% | -0.2% | – | – | – | |
| 0.7% | 0.5% | 0.9% | 1.0% | -2.0% | 45.3% | -6.1% | 2,431.1% | -14.5% | -3.7% | -2.5% | -28.7% | |
| 32.4% | 71.1% | 339.4% | 1.3% | 1,520.4% | 44.9% | -5.2% | 4,316.3% | -34.2% | 292.2% | -4.1% | -27.3% | |
| -26.2% | 187.3% | 326.0% | -137.4% | 446.0% | 33.6% | -211.9% | -8,334.4% | -1,286.7% | 316.9% | -154.6% | -137.8% | |
| -58.6% | 112.2% | -28.2% | -118.0% | -638.5% | 48.3% | -396.8% | -7,237.7% | -1,901.1% | -413.5% | 239.0% | -1,875.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.